Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DI17E6

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Integrins that contain an integrin αV subunit contribute to multiple functions that promote cancer progression. The goal of this… Expand
Is this relevant?
2014
2014
BACKGROUND EMD 525797 (DI17E6) is a deimmunized, humanized monoclonal immunoglobulin G2 antibody against the αv subunit of human… Expand
  • table 2
  • table 1
  • table 3
  • figure 1
  • table 4
Is this relevant?
2014
2014
5030 Background: The humanized monoclonal IgG2 antibody abituzumab inhibits αv integrins expressed on CRPC cells, tumor vessels… Expand
Is this relevant?
2014
2014
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Purpose: Integrins are implicated in resistance of solid… Expand
Is this relevant?
2014
2014
ABSTRACT Aim: Abituzumab, a humanized monoclonal IgG2 antibody (Ab) targeting av integrins, suppressed tumor growth in… Expand
Is this relevant?
2013
2013
Purpose We evaluated the safety, tolerability, and pharmacokinetics (PK) of EMD 525797 (DI17E6), a humanized monoclonal antibody… Expand
  • table 1
  • table 2
  • table 3
  • table 3
  • figure 1
Is this relevant?
2012
2012
231 Background: EMD 525797 is a humanized monoclonal IgG2 antibody specifically targeting αv integrins involved in tumor… Expand
Is this relevant?
2011
2011
e15060 Background: Integrins are cell surface receptors contributing to tumor progression by increasing cell migration, invasion… Expand
Is this relevant?
2011
2011
Introduction: Integrins play an important role in cancer. They are highly expressed in angiogenic, proliferating tumor blood… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Specific transport of anti-cancer drugs into tumor cells may result in increased therapeutic efficacy and decreased adverse… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?